| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 1.129 | 27.412 | 71.350 | 11.273 | - |
| Total Income - EUR | - | - | - | - | 0 | 1.668 | 27.412 | 71.351 | 11.273 | - |
| Total Expenses - EUR | - | - | - | - | 7.528 | 56.024 | 103.999 | 101.091 | 37.700 | - |
| Gross Profit/Loss - EUR | - | - | - | - | -7.528 | -54.356 | -76.587 | -29.740 | -26.427 | - |
| Net Profit/Loss - EUR | - | - | - | - | -7.528 | -54.367 | -76.861 | -30.453 | -26.540 | - |
| Employees | - | - | - | - | 1 | 3 | 5 | 6 | 1 | - |
Check the financial reports for the company - Minfound Medical System Europe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 30 | 216.981 | 191.276 | 163.404 | 134.528 | - |
| Current Assets | - | - | - | - | 2.141 | 9.523 | 7.501 | 2.862 | 169 | - |
| Inventories | - | - | - | - | 0 | 712 | 2.698 | 657 | 0 | - |
| Receivables | - | - | - | - | 0 | 6.448 | 204 | 1.278 | 112 | - |
| Cash | - | - | - | - | 2.141 | 2.362 | 4.599 | 926 | 57 | - |
| Shareholders Funds | - | - | - | - | 1.955 | -52.450 | -128.148 | -158.999 | -185.056 | - |
| Social Capital | - | - | - | - | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | - |
| Debts | - | - | - | - | 216 | 281.639 | 326.925 | 325.264 | 319.754 | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Minfound Medical System Europe S.r.l.